Kingdon Capital Management’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-387,294
| Closed | -$1.53M | – | 106 |
|
|
2017
Q3 | $1.53M | Sell |
387,294
-763,653
| -66% | -$3.02M | 0.1% | 86 |
|
|
2017
Q2 | $3.73M | Sell |
1,150,947
-561,011
| -33% | -$1.82M | 0.25% | 63 |
|
|
2017
Q1 | $7.79M | Sell |
1,711,958
-903,889
| -35% | -$4.11M | 0.43% | 52 |
|
|
2016
Q4 | $6.57M | Sell |
2,615,847
-212,042
| -7% | -$532K | 0.32% | 63 |
|
|
2016
Q3 | $8.82M | Buy |
2,827,889
+569,969
| +25% | +$1.78M | 0.4% | 50 |
|
|
2016
Q2 | $3.84M | Hold |
2,257,920
| – | – | 0.21% | 63 |
|
|
2016
Q1 | $4.06M | Sell |
2,257,920
-338,569
| -13% | -$609K | 0.22% | 66 |
|
|
2015
Q4 | $8.75M | Buy |
2,596,489
+194,265
| +8% | +$655K | 0.43% | 42 |
|
|
2015
Q3 | $12.8M | Sell |
2,402,224
-5,188
| -0.2% | -$27.7K | 0.62% | 31 |
|
|
2015
Q2 | $15.6M | Buy |
2,407,412
+884,137
| +58% | +$5.72M | 0.61% | 42 |
|
|
2015
Q1 | $7.45M | Sell |
1,523,275
-30,900
| -2% | -$151K | 0.32% | 73 |
|
|
2014
Q4 | $7.82M | Buy |
1,554,175
+126,500
| +9% | +$636K | 0.34% | 73 |
|
|
2014
Q3 | $7.28M | Buy |
1,427,675
+230,000
| +19% | +$1.17M | 0.33% | 66 |
|
|
2014
Q2 | $7.8M | Buy |
1,197,675
+84,200
| +8% | +$548K | 0.3% | 82 |
|
|
2014
Q1 | $10.5M | Buy |
1,113,475
+251,673
| +29% | +$2.38M | 0.54% | 46 |
|
|
2013
Q4 | $5.41M | Buy |
+861,802
| New | +$5.41M | 0.25% | 94 |
|